Document:

Exhibit 10.1

NONE OF THE SECURITIES TO WHICH THIS PRIVATE  PLACEMENT  SUBSCRIPTION  AGREEMENT
(THE  "SUBSCRIPTION  AGREEMENT")  RELATES HAVE BEEN REGISTERED  UNDER THE UNITED
STATES  SECURITIES  ACT OF 1933, AS AMENDED (THE "1933 ACT"),  OR ANY U.S. STATE
SECURITIES  LAWS, AND, UNLESS SO REGISTERED,  NONE MAY BE OFFERED OR SOLD IN THE
UNITED  STATES OR TO U.S.  PERSONS (AS  DEFINED  HEREIN)  EXCEPT  PURSUANT TO AN
EXEMPTION  FROM,  OR  IN  A  TRANSACTION   NOT  SUBJECT  TO,  THE   REGISTRATION
REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE
STATE SECURITIES LAWS.

                             SUBSCRIPTION AGREEMENT

                             (Offshore Subscribers)

TO:  GURU HEALTH INC. (THE "COMPANY")
     a company with offices at #10 - 1019 17th SW, Calgary, AB, T2T 0A7

                          Purchase of Convertible Note

1. SUBSCRIPTION AND USE OF PROCEEDS.

1.1 On the basis of the  representations and warranties and subject to the terms
and  conditions  set  forth  herein,  _________________________________.,   (the
"SUBSCRIBER")  hereby  irrevocably  subscribes  for and agrees to  purchase  one
convertible  note (the "NOTE") from the Company for an aggregate  purchase price
of $125,000 (the "SUBSCRIPTION PROCEEDS"), substantially in the form attached to
this  Subscription  Agreement as Exhibit "A" (the  subscription and agreement to
purchase being the "SUBSCRIPTION").

1.2 On the basis of the  representations and warranties and subject to the terms
and conditions set forth herein,  the Company hereby  irrevocably agrees to sell
the Note to the Subscriber.

1.3 Subject to the terms hereof,  the  Subscription  will be effective  upon its
acceptance by the Company.

1.4  Unless  otherwise  provided,   all  dollar  amounts  referred  to  in  this
Subscription Agreement are in lawful money of the United States of America.

2. PAYMENT.

2.1 the  Subscription  Proceeds  pertaining to the purchase of the Note shall be
paid on or before the Closing Date (as defined in Section 4.1,  below) by cheque
or wire transfer to the Company.

3. DOCUMENTS REQUIRED FROM SUBSCRIBER.

3.1 The Subscriber must:

     (a)  complete,  sign and  return to the  Company an  executed  copy of this
          Subscription Agreement prior to the Closing Date; and,

     (b)  complete,  sign and  return to the  Company  an  executed  copy of the
          Investor Questionnaire attached as Annex B; and

     (c)  complete,  sign and  return to the  Company  as soon as  possible,  on
          request by the Company,  any  documents,  questionnaires,  notices and
          undertakings  as  may  be  required  by  regulatory   authorities  and
          applicable law

                                     (collectively the "TRANSACTION DOCUMENTS.")
<PAGE>
4. CLOSING.

4.1 There shall be no formal closing  ceremony with respect to the  transactions
contemplated by this Agreement.  Instead, the parties shall execute and exchange
the  Transaction  Documents  by  facsimile  and  email  and the  closing  of the
transactions  contemplated  by this  Agreement  shall be deemed to have occurred
(the "CLOSING") on the date (the "CLOSING  DATE") that the Company  receives the
Subscription Proceeds in full. There may be multiple Closings

5. ACKNOWLEDGEMENTS OF SUBSCRIBER.

5.1 The Subscriber acknowledges and agrees that:

     (a)  Neither the Note nor the shares of common stock ("SHARES") that may be
          issued upon a  conversion  of the Note (the Note and the Shares may be
          hereinafter referred to collectively as the "SECURITIES") have been or
          will be registered  under the 1933 Act, or under any state  securities
          or "blue sky" laws of any state of the United States,  and,  unless so
          registered,  none of them may be offered or sold in the United  States
          or, directly or indirectly,  to a U.S. Person, as that term is defined
          in  Regulation  S under  the  1933 Act  ("REGULATION  S"),  except  in
          accordance  with  the  provisions  of  Regulation  S,  pursuant  to an
          effective registration statement under the 1933 Act, or pursuant to an
          exemption from, or in a transaction  not subject to, the  registration
          requirements  of the  1933  Act and in each  case in  accordance  with
          applicable state securities laws;

     (b)  the Company has not  undertaken  to, and will have no  obligation  to,
          register the Securities, or any of them, under the 1933 Act;

     (c)  it has received and carefully read this Subscription Agreement;

     (d)  the decision to execute this  Subscription  Agreement  and acquire the
          Note   hereunder   has  not  been  based  upon  any  oral  or  written
          representation  as to fact or  otherwise  made by or on  behalf of the
          Company,  and  such  decision  is  based  entirely  upon a  review  of
          information (the adequacy of which is hereby  acknowledged)  about the
          Company  that is  available  to any  member of the public on the EDGAR
          database  maintained by the U.S.  Securities  and Exchange  Commission
          (the "SEC") at www.sec.gov;

     (e)  there  are  risks   associated  with  an  investment  in  the  Company
          including, by way of example and not in limitation, the specific risks
          identified in the Company's  most recent  periodic  reports filed with
          the SEC and available for viewing at the SEC's website at www.SEC.gov;

     (f)  it  and  its  advisor(s)  have  had a  reasonable  opportunity  to ask
          questions of and receive  answers from the Company in connection  with
          the sale of the Note hereunder,  and to obtain additional information,
          to  the  extent   possessed  or  obtainable  by  the  Company  without
          unreasonable effort or expense;

     (g)  all  information  which the  Subscriber has provided to the Company is
          correct and  complete  as of the date the  Subscription  Agreement  is
          signed, and if there should be any change in such information prior to
          this  Subscription  Agreement  being  executed  by  the  Company,  the
          Subscriber will immediately provide the Company with such information;

     (h)  the Company is entitled to rely on the  representations and warranties
          of the  Subscriber  contained in this  Subscription  Agreement and the
          Subscriber  will hold the Company  harmless from any loss or damage it
          may  suffer  as a result  of the  Subscriber's  failure  to  correctly
          complete this Subscription Agreement;

     (i)  the Subscriber has been advised to consult the Subscriber's own legal,
          tax and other  advisors  with  respect  to the  merits and risks of an
          investment in the  Securities  and with respect to  applicable  resale

                                       2
<PAGE>
          restrictions,  and it is solely responsible (and the Company is not in
          any way responsible) for compliance with:

          (i)  any applicable  laws of the  jurisdiction in which the Subscriber
               is resident in connection with the distribution of the Securities
               hereunder, and

          (ii) applicable resale restrictions;

     (j)  none of the  Securities  are listed on any stock exchange or automated
          dealer  quotation  system and no  representation  has been made to the
          Subscriber  that any of the Securities will become listed on any stock
          exchange or automated dealer quotation  system,  except that currently
          certain  market makers make market in the Shares of the Company on the
          OTC  Bulletin  Board  operated by the  Financial  Industry  Regulatory
          Authority ("FINRA");

     (k)  none of the  Securities  may be offered or sold by the Subscriber to a
          U.S.  Person (as  defined in Section 0,  below,  or for the account or
          benefit of a U.S.  Person (other than a distributor)  prior to the end
          of the Distribution Compliance Period (as defined herein);

     (l)  the  Subscriber is not acquiring the Note as a result of, and will not
          itself  engage in, any  "directed  selling  efforts"  (as that term is
          defined in  Regulation  S under the 1933 Act) in the United  States in
          respect  of  the   Securities   which  would  include  any  activities
          undertaken for the purpose of, or that could reasonably be expected to
          have the effect of,  conditioning  the market in the United States for
          the  resale  of any of the  Securities;  provided,  however,  that the
          Subscriber may sell or otherwise dispose of the Securities pursuant to
          registration  thereof  under  the  1933 Act and any  applicable  state
          securities   laws  or  under  an  exemption  from  such   registration
          requirements;

     (m)  the Company will refuse to register any transfer of the Securities not
          made in accordance with the provisions of Regulation S, pursuant to an
          effective  registration statement under the 1933 Act or pursuant to an
          available exemption from the registration requirements of the 1933 Act
          and in each case in accordance with applicable state securities laws;

     (n)  neither  the  SEC nor  any  other  securities  commission  or  similar
          regulatory  authority  has  reviewed  or passed  on the  merits of the
          Securities;

     (o)  no documents in connection  with the sale of the Note  hereunder  have
          been reviewed by the SEC or any state securities administrators;

     (p)  there  is no  government  or  other  insurance  covering  any  of  the
          Securities;

     (q)  the issuance and sale of the Securities to the Subscriber  will not be
          completed  if it would be  unlawful  or if, in the  discretion  of the
          Company  acting  reasonably,  it is not in the best  interests  of the
          Company;

     (r)  the Subscriber is purchasing  the Securities  pursuant to an exemption
          from the  registration  and the prospectus  requirements of applicable
          securities  legislation  on the  basis  that the  Subscriber  is not a
          resident of either the United States or Canada and, as a consequence:

          (i)  is  restricted  from using most of the civil  remedies  available
               under securities legislation,

          (ii) may not receive  information  that would otherwise be required to
               be provided under securities legislation, and

          (iii)the  Company is  relieved  from  certain  obligations  that would
               otherwise apply under securities legislation; and

                                       3
<PAGE>
     (s)  the  statutory  and  regulatory  basis  for the  exemption  from  U.S.
          registration  requirements claimed for the offer of the Note, although
          in technical  compliance  with Regulation S, would not be available if
          the  offering  is part of a plan or scheme  to evade the  registration
          provisions of the 1933 Act or any applicable state securities laws; .

6. REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE SUBSCRIBER.

6.1 The  Subscriber  hereby  represents  and warrants to and covenants  with the
Company  (which  representations,  warranties  and  covenants  shall survive the
Closing), and acknowledges that the Company is relying thereon, that:

     (a)  the  Subscriber  is not a U.S.  Person  as  that  term is  defined  in
          Regulation S;

     (b)  the  Subscriber  is not  acquiring the Note for the account or benefit
          of, directly or indirectly, any U.S. Person as that term is defined in
          Regulation S;

     (c)  the  Subscriber  is  resident  in the  jurisdiction  set out under the
          heading "Name and Address of Subscriber" on the signature page of this
          Subscription   Agreement  and  the  sale  of  the  Securities  to  the
          Subscriber as contemplated  in this  Subscription  Agreement  complies
          with or is exempt from the  applicable  securities  legislation of the
          jurisdiction of residence of the Subscriber;

     (d)  the Subscriber has the legal capacity and competence to enter into and
          execute this  Subscription  Agreement and to take all actions required
          pursuant  hereto and, if the Subscriber is a  corporation,  it is duly
          incorporated and validly subsisting under the laws of its jurisdiction
          of  incorporation  and  all  necessary  approvals  by  its  directors,
          shareholders and others have been obtained to authorize  execution and
          performance   of  this   Subscription   Agreement  on  behalf  of  the
          Subscriber;

     (e)  if the Subscriber is a corporation or other entity,  the entering into
          of  this  Subscription  Agreement  and the  transactions  contemplated
          hereby do not and will not result in the violation of any of the terms
          and provisions of any law  applicable to, or the constating  documents
          of, the Subscriber or of any agreement,  written or oral, to which the
          Subscriber  may be a party or by  which  the  Subscriber  is or may be
          bound;

     (f)  the  Subscriber  has duly  executed and  delivered  this  Subscription
          Agreement  and  upon  acceptance   thereof  by  the  Company  it  will
          constitutes   a  valid  and  binding   agreement  of  the   Subscriber
          enforceable against the Subscriber in accordance with its terms;

     (g)  the  Subscriber is acquiring  the  Securities as principal for its own
          account for  investment  purposes  only and not for the account of any
          other person and not for distribution, assignment or resale to others,
          and no other  person has a direct or indirect  beneficial  interest in
          such  Securities,  and it  has  not  subdivided  its  interest  in the
          Securities with any other person;

     (h)  the  Subscriber  is  outside  the United  States  when  receiving  and
          executing  this  Subscription  Agreement  and is acquiring the Note as
          principal for the  Subscriber's  own account for  investment  purposes
          only,  and  not  with a view  to,  or  for,  resale,  distribution  or
          fractionalisation  thereof,  in whole or in part,  and no other person
          has a direct or indirect beneficial interest in the Securities;

     (i)  the  Subscriber  is  aware  that  an  investment  in  the  Company  is
          speculative and involves certain risks, including the possible loss of
          the entire  investment  and it has carefully  read and  considered the
          matters set forth under the heading  "Risk  Factors"  appearing in the
          Company's  Forms 10-K,  10-Q, 8-K and any other filings filed with the
          SEC;

     (j)  the Subscriber has made an independent  examination and  investigation
          of an investment in the Securities and the Company and has depended on
          the advice of its legal and  financial  advisors  and agrees  that the

                                       4
<PAGE>
          Company  will  not  be  responsible  in any  way  whatsoever  for  the
          Subscriber's decision to invest in the Securities and the Company;

     (k)  the  Subscriber  (i) has adequate net worth and means of providing for
          its current financial needs and possible personal contingencies,  (ii)
          has no need for  liquidity  in this  investment,  and (iii) is able to
          bear the economic  risks of an  investment  in the  Securities  for an
          indefinite period of time;

     (l)  the Subscriber understands and agrees that the Company and others will
          rely   upon  the   truth  and   accuracy   of  the   acknowledgements,
          representations   and  agreements   contained  in  this   Subscription
          Agreement   and   agrees   that  if  any  of  such   acknowledgements,
          representations  and  agreements  are no longer  accurate or have been
          breached, the Subscriber shall promptly notify the Company;

     (m)  the Subscriber has the legal capacity and competence to enter into and
          execute this  Subscription  Agreement and to take all actions required
          pursuant hereto;

     (n)  the  Subscriber  has duly  executed and  delivered  this  Subscription
          Agreement  and it  constitutes  a valid and binding  agreement  of the
          Subscriber  enforceable  against the Subscriber in accordance with its
          terms;

     (o)  the Subscriber is not an  underwriter  of, or dealer in, the Company's
          Shares, nor is the Subscriber participating, pursuant to a contractual
          agreement or otherwise, in the distribution of any of the Shares;

     (p)  the Subscriber is not an  underwriter  of, or dealer in, the Company's
          Shares, nor is the Subscriber participating, pursuant to a contractual
          agreement or otherwise, in the distribution of any of the Securities;

     (q)  the Subscriber  understands and agrees that offers and sales of any of
          the Securities prior to the expiration of restricted  period after the
          date of original  issuance  of the  Securities  (the six month  period
          hereinafter referred to as the "DISTRIBUTION COMPLIANCE PERIOD") shall
          only be made in compliance  with the safe harbor  provisions set forth
          in Regulation S, pursuant to the  registration  provisions of the 1933
          Act or an exemption therefrom, and that all offers and sales after the
          Distribution  Compliance  Period shall be made only in compliance with
          the registration  provisions of the 1933 Act or an exemption therefrom
          and in each case only in accordance with applicable  state  securities
          laws;

     (r)  the  Subscriber  agrees  not to  engage  in any  hedging  transactions
          involving  any of  the  Securities  unless  such  transactions  are in
          compliance  with the  provisions of the 1933 Act and in each case only
          in accordance with applicable state securities laws;

     (s)  the  Subscriber  (i) is able to fend for  itself in the  Subscription;
          (ii) has such  knowledge  and  experience  in  financial  and business
          matters  as to be capable  of  evaluating  the merits and risks of its
          investment  in the  Securities  and the  Company;  and  (iii)  has the
          ability to bear the economic risks of its  prospective  investment and
          can afford the complete loss of such investment;

     (t)  the Subscriber will indemnify the Company  against,  and will hold the
          Company and, where  applicable,  its respective  directors,  officers,
          employees,  agents,  advisors and shareholders  harmless from, any and
          all loss, liability,  claim, damage and expense whatsoever (including,
          but not limited to, any and all fees,  costs and  expenses  whatsoever
          reasonably  incurred in investigating,  preparing or defending against
          any claim, lawsuit, administrative proceeding or investigation whether
          commenced   or   threatened)   arising   out  of  or  based  upon  any
          representation  or warranty of the Subscriber  contained  herein or in
          any document  furnished by the Subscriber to the Company in connection
          herewith being untrue in any material respect or any breach or failure
          by the Subscriber to comply with any covenant or agreement made by the
          Subscriber to the Company in connection therewith;

                                       5
<PAGE>
     (u)  the  Subscriber  is  not  aware  of  any  advertisement  of any of the
          Securities and is not acquiring the Securities as a result of any form
          of   general    solicitation   or   general   advertising    including
          advertisements, articles, notices or other communications published in
          any  newspaper,  magazine or similar media or broadcast  over radio or
          television,  or any  seminar  or  meeting  whose  attendees  have been
          invited by general solicitation or general advertising; and

     (v)  no  person   has  made  to  the   Subscriber   any   written  or  oral
          representations:

          (i)  that any person will resell or repurchase any of the Securities,

          (ii) that any  person  will  refund the  purchase  price of any of the
               Securities,

          (iii) as to the future price or value of any of the Securities, or

          (iv) that any of the Securities  will be listed and posted for trading
               on any stock  exchange or automated  dealer  quotation  system or
               that  application  has  been  made to list  and  post  any of the
               Securities  of the  Company on any stock  exchange  or  automated
               dealer  quotation  system,  except that  currently  the Company's
               common shares are quoted on the over-the-counter  market operated
               by the Over-The-Counter Bulletin Board operated by FINRA.

6.2 In this  Subscription  Agreement,  the term  "U.S.  Person"  shall  have the
meaning ascribed thereto in Regulation S.

7. ACKNOWLEDGEMENT AND WAIVER.

7.1 The Subscriber has acknowledged that the decision to purchase the Securities
was solely made on the basis of  information  available to the Subscriber on the
EDGAR  database  maintained by the SEC at  www.sec.gov.  The  Subscriber  hereby
waives,  to the  fullest  extent  permitted  by law,  any rights of  withdrawal,
rescission or compensation for damages to which the Subscriber might be entitled
in connection with the distribution of the Securities.

8. LEGENDING OF SUBJECT SECURITIES.

8.1 The Subscriber hereby acknowledges that that upon the issuance thereof,  and
until  such  time  as the  same  is no  longer  required  under  the  applicable
securities  laws  and  regulations,  the  certificates  representing  any of the
Securities will bear a legend in substantially the following form:

     NONE  OF THE  SECURITIES  TO  WHICH  THIS  PRIVATE  PLACEMENT  SUBSCRIPTION
     AGREEMENT (THE "SUBSCRIPTION AGREEMENT") RELATES HAVE BEEN REGISTERED UNDER
     THE UNITED STATES  SECURITIES ACT OF 1933, AS AMENDED (THE "1933 ACT"),  OR
     ANY U.S. STATE  SECURITIES  LAWS,  AND,  UNLESS SO REGISTERED,  NONE MAY BE
     OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS DEFINED HEREIN)
     EXCEPT  PURSUANT TO AN EXEMPTION  FROM, OR IN A TRANSACTION NOT SUBJECT TO,
     THE  REGISTRATION  REQUIREMENTS  OF THE 1933 ACT AND IN EACH  CASE  ONLY IN
     ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

The Subscriber  hereby  acknowledges and agrees to the Company making a notation
on its records or giving instructions to the registrar and transfer agent of the
Company  in order to  implement  the  restrictions  on  transfer  set  forth and
described in this Subscription Agreement.

9. COSTS.

9.1 The Subscriber  acknowledges and agrees that all costs and expenses incurred
by the Subscriber  (including any fees and  disbursements of any special counsel
retained  by the  Subscriber)  relating  to the  purchase  of the Note or to the
conversion  of  the  Note  or  the  Conversion  Shares  shall  be  borne  by the
Subscriber.

                                       6
<PAGE>
10. GOVERNING LAW.

10.1 This Subscription  Agreement is governed by the laws of the State of Nevada
and the federal laws  applicable  thereto.  The  Subscriber,  in its personal or
corporate  capacity and, if applicable,  on behalf of each beneficial  purchaser
for whom it is acting,  irrevocably attorns to the jurisdiction of the courts of
the State of Nevada.

11. SURVIVAL.

11.1   This   Subscription   Agreement,   including   without   limitation   the
representations,  warranties and covenants  contained herein,  shall survive and
continue  in full  force and  effect  and be  binding  upon the  parties  hereto
notwithstanding  the  completion  of the purchase of the Note by the  Subscriber
pursuant hereto.

12. ASSIGNMENT.

12.1 This Subscription Agreement is assignable.

13. SEVERABILITY.

13.1 The  invalidity or  unenforceability  of any  particular  provision of this
Subscription  Agreement shall not affect or limit the validity or enforceability
of the remaining provisions of this Subscription Agreement.

14. ENTIRE AGREEMENT.

14.1 Except as  expressly  provided in this  Subscription  Agreement  and in the
agreements, instruments and other documents contemplated or provided for herein,
this  Subscription  Agreement  contains the entire agreement between the parties
with  respect  to the sale of the  Securities  and  there  are no  other  terms,
conditions,  representations or warranties,  whether expressed, implied, oral or
written,  by statute or common  law,  by the  Company  or by anyone  else.  This
subscription  may only be amended by instrument in writing signed by the parties
hereto.

15. NOTICES.

15.1 All  notices  and other  communications  hereunder  shall be in writing and
shall be deemed to have been duly given if mailed or transmitted by any standard
form of  telecommunication.  Notices to the Subscriber  shall be directed to the
address on the signature page of this Subscription  Agreement and notices to the
Company  shall  be  directed  to it at Guru  Health  Inc.,  #10 - 1019  17th SW,
Calgary, AB, T2T 0A7, Attention: President.

16. COUNTERPARTS AND ELECTRONIC MEANS.

16.1 This Subscription  Agreement may be executed in any number of counterparts,
each of which, when so executed and delivered,  shall constitute an original and
all of which together shall  constitute one instrument.  Delivery of an executed
copy of this  Subscription  Agreement by electronic  facsimile  transmission  or
other means of electronic communication capable of producing a printed copy will
be deemed to be execution and delivery of this Subscription  Agreement as of the
date hereinafter set forth.

17. REGISTRATION INSTRUCTIONS.

17.1 The Subscriber hereby directs the Company to cause any Note issued pursuant
to this  Subscription  Agreement to be registered on the books of the Company as
directed on the signature page of this Agreement.

                                       7
<PAGE>
IN WITNESS WHEREOF the Subscriber has duly executed this Subscription  Agreement
as of the date of acceptance by the Company.

                           Name of Subscriber - Please type or print)

                           /s/ Authorized Signatory
                           -----------------------------------------------------
                           (Signature and, if applicable, Office)

                           REGISTRATION INFORMATION (IF DIFFERENT FROM ABOVE)

                           -----------------------------------------------------
                           (Name of Subscriber - Please type or print)

                           -----------------------------------------------------
                           (Signature and, if applicable, Office)

                           -----------------------------------------------------
                           (Address of Subscriber)

                           -----------------------------------------------------
                           (City, State or Province, Postal Code of Subscriber)

                           -----------------------------------------------------
                           (Country of Subscriber)

                           -----------------------------------------------------
                           (Fax and/or E-mail Address of Subscriber)

                                   ACCEPTANCE

The  above-mentioned  Subscription  Agreement  in  respect of the Note is hereby
accepted by Guru Health Inc.

DATED at Forth Worth, Texas, the 18th day of March, 2012.

GURU HEALTH INC.

Per: /s/ Matthew Christopherson
     ------------------------------------------
     Matthew Christopherson

                                       8
<PAGE>
                                   EXHIBIT "A"

                            FORM OF CONVERTIBLE NOTE

THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES INTO WHICH THIS SECURITY IS
CONVERTIBLE HAVE BEEN OFFERED IN AN OFFSHORE  TRANSACTION TO A PERSON WHO IS NOT
A U.S.  PERSON (AS DEFINED  HEREIN)  PURSUANT TO  REGULATION  S UNDER THE UNITED
STATES SECURITIES ACT OF 1933, AS AMENDED (THE "1933 ACT").

NONE OF THE SECURITIES  REPRESENTED  HEREBY NOR THE SECURITIES  INTO WHICH THESE
SECURITIES ARE CONVERTIBLE  HAVE BEEN REGISTERED UNDER THE 1933 ACT, OR ANY U.S.
STATE  SECURITIES  LAWS, AND, UNLESS SO REGISTERED,  MAY NOT BE OFFERED OR SOLD,
DIRECTLY  OR  INDIRECTLY,  IN THE UNITED  STATES OR TO A U.S.  PERSON  EXCEPT IN
ACCORDANCE  WITH THE PROVISIONS OF REGULATION S UNDER THE 1933 ACT,  PURSUANT TO
AN  EFFECTIVE  REGISTRATION  STATEMENT  UNDER THE 1933 ACT,  OR  PURSUANT  TO AN
AVAILABLE  EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE  REGISTRATION
REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE
STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THIS SECURITY
AND THE SECURITIES  INTO WHICH THIS SECURITY IS CONVERTIBLE MAY NOT BE CONDUCTED
UNLESS IN COMPLIANCE WITH THE 1933 ACT. "UNITED STATES" AND "U.S. PERSON" ARE AS
DEFINED BY REGULATION S UNDER THE 1933 ACT.

DATED:  MAY 18, 2012

                                                                   U.S. $125,000

                                CONVERTIBLE NOTE

FOR  VALUE  RECEIVED,  GURU  HEALTH  INC.  (the  "COMPANY")  promises  to pay to
___________________, or its registered assignS (the "HOLDER"), the principal sum
of One Hundred Twenty Five Thousand Dollars ($125,000) in lawful currency of the
United States (the  "PRINCIPAL  AMOUNT") on May 18, 2014 or such earlier date as
the Note may be  permitted  to be repaid as provided  hereunder  (the  "MATURITY
DATE"),  with 10%  annual  interest,  to the  Holder on the  earlier  of (i) the
Conversion Date (as hereafter  defined) and (ii) the Maturity Date (except that,
if any such date is not a Business  Day,  then such payment  shall be due on the
next succeeding Business Day) in cash. THE COMPANY MAY PREPAY ANY PORTION OF THE
PRINCIPAL AMOUNT WITHOUT THE PRIOR WRITTEN CONSENT OF THE HOLDER.

This Note is subject to the following additional provisions:

1. OTHER AGREEMENTS.

1.1 This Note has been issued pursuant to a subscription  agreement  between the
Company  and the  Holder  dated  May 18,  2012  (the  "SUBSCRIPTION  AGREEMENT")
pursuant to which the Holder  purchased  this Note,  and this Note is subject in
all respects to the terms of the  Subscription  Agreement and  incorporates  the
terms of the Subscription Agreement to the extent that they do not conflict with
the terms of this Note. This Note may be transferred or assigned.

                                       9
<PAGE>
2. EVENTS OF DEFAULT.

2.1 "Event of Default",  wherever  used herein,  means any one of the  following
events  (whatever the reason and whether it shall be voluntary or involuntary or
effected by operation of law or pursuant to any judgment, decree or order of any
court, or any order,  rule or regulation of any  administrative  or governmental
body):

     (a)  any default in the payment of the Principal  Amount of this Note, free
          of any claim of  subordination,  as and when the same shall become due
          and payable  (whether on a Conversion  Date or the Maturity Date or by
          acceleration or otherwise);

     (b)  the  Company  shall fail to observe or perform  any other  covenant or
          agreement  contained in this Note or the Subscription  Agreement which
          failure is not cured,  if  possible to cure,  within 30 calendar  days
          after notice of such default is sent by the Holder to the Company; or

     (c)  the Company or any of its  subsidiaries  (each a  "SUBSIDIARY")  shall
          commence,  or there  shall be  commenced  against  the  Company or any
          Subsidiary a case under any applicable  bankruptcy or insolvency  laws
          as now or hereafter in effect or any successor thereto, or the Company
          or  any   Subsidiary   commences  any  other   proceeding   under  any
          reorganization,  arrangement,  adjustment of debt,  relief of debtors,
          dissolution,   insolvency  or   liquidation  or  similar  law  of  any
          jurisdiction  whether  now or  hereafter  in  effect  relating  to the
          Company or any Subsidiary or there is commenced against the Company or
          any Subsidiary  any such  bankruptcy,  insolvency or other  proceeding
          which remains  undismissed  for a period of 60 days; or the Company or
          any Subsidiary is adjudicated  insolvent or bankrupt;  or any order of
          relief  or other  order  approving  any  such  case or  proceeding  is
          entered;  or the Company or any Subsidiary  suffers any appointment of
          any  custodian  or the  like  for it or any  substantial  part  of its
          property which  continues  undischarged or unstayed for a period of 60
          days; or the Company or any Subsidiary makes a general  assignment for
          the benefit of  creditors;  or the Company shall fail to pay, or shall
          state that it is unable to pay,  or shall be unable to pay,  its debts
          generally as they become due; or the Company or any  Subsidiary  shall
          call  a  meeting  of  its  creditors   with  a  view  to  arranging  a
          composition,  adjustment or restructuring of its debts; or the Company
          or any  Subsidiary  shall  by  any  act or  failure  to act  expressly
          indicate  its consent to,  approval of or  acquiescence  in any of the
          foregoing; or any corporate or other action is taken by the Company or
          any Subsidiary for the purpose of effecting any of the foregoing.

2.2 If any Event of Default  occurs,  the full Principal  Amount,  together with
interest and other amounts owing in respect  thereof to the date of acceleration
shall become,  at the Holder's  election,  immediately  due and payable in cash.
Upon payment of the full  Principal  Amount,  together  with  interest and other
amounts  owing in  respect  thereof,  in  accordance  herewith,  this Note shall
promptly be  surrendered  to or as directed by the Company.  The Holder need not
provide and the Company hereby waives any presentment,  demand, protest or other
notice of any kind, and the Holder may immediately and without expiration of any
grace period  enforce any and all of its rights and remedies  hereunder  and all
other remedies  available to it under  applicable  law. Such  declaration may be
rescinded and annulled by the Holder at any time prior to payment  hereunder and
the Holder  shall have all rights as a Note holder  until such time,  if any, as
the full  payment  under this  Section  shall have been  received by it. No such
rescission or annulment  shall affect any subsequent  Event of Default or impair
any right consequent thereon.

3. CONVERSION.

3.1  At any  time  after  the  Financing  Date  until  this  Note  is no  longer
outstanding,  this Note may be converted into Conversion  Shares at any time and
from time-to-time,  in whole or in part, at the option of the Holder. The Holder
shall  effect  conversions  by  delivering  to the Company the form of Notice of
Conversion  attached  hereto as Annex A (a "NOTICE OF  CONVERSION"),  specifying
therein  the  amount of  principal  to be  converted  and the date on which such
conversion is to be effected (a "CONVERSION DATE");  provided that the date upon
which any such  conversion  may be effected may not be less than 5 calendar days
following  the date of delivery of the Notice of  Conversion.  If no  Conversion

                                       10
<PAGE>
Date is specified in a Notice of Conversion,  the  Conversion  Date shall be the
date that is 5 calendar days after such Notice of Conversion is delivered to the
Company.  To effect conversions  hereunder,  the Holder shall not be required to
physically  surrender the Note to the Company unless the entire principal amount
of this Note has been so converted.  Conversions hereunder shall have the effect
of lowering the outstanding  principal amount of this Note in an amount equal to
the applicable  conversion.  The Holder and the Company shall  maintain  records
showing the principal  amount  converted and the date of such  conversions.  The
Company  shall  deliver  any  objection  to any Notice of  Conversion  within 10
business days of receipt of such notice. The Holder, by acceptance of this Note,
acknowledges  and agrees that, by reason of the  provisions  of this  paragraph,
following  conversion  of a portion  of this Note,  the  unpaid and  unconverted
principal  amount of this Note may be less  than the  amount  stated on the face
hereof.

3.2  The  number  of  Conversion  Shares  issuable  upon  a  conversion  of  any
outstanding  principal  under  the Note  shall  be  determined  by the  quotient
obtained by dividing (x) by (y) where (x) is equal to the amount of  outstanding
principal  to be  converted  and (y) is the  Conversion  Price  (as  hereinafter
defined).

3.3 Not later than five Trading Days after any Conversion Date, the Company will
deliver to the Holder a certificate or certificates  representing the Conversion
Shares  (bearing  such  legends as may be required by  applicable  law and those
required by the  Subscription  Agreement)  representing the number of Conversion
Shares being acquired upon the conversion of Note.

3.4 The conversion  price (the  "CONVERSION  PRICE") in effect on any Conversion
Date shall be shall mean $0.50 per share.

3.5  At any  time  after  the  Financing  Date  until  this  Note  is no  longer
outstanding,  this Note may be converted into Conversion  Shares at any time and
from  time-to-time,  in whole or in part,  at the  option  of the  Company.  The
Company shall effect  conversions  by delivering to the Holder written notice of
conversion  specifying  therein the amount of principal to be converted  and the
date on which such conversion is to be effected (a "CONVERSION DATE");

3.6 The Company  covenants  that it will at all times reserve and keep available
out of its authorized and unissued  shares of Common Stock such number of shares
as is necessary in order to ensure that a sufficient  number are  available  for
the purpose of issuance of Conversion  Shares upon conversion of this Note, free
from  pre-emptive  rights  or any other  actual  contingent  purchase  rights of
Persons other than the Holder.  The Company covenants that all Conversion Shares
shall,  upon issue,  be duly and validly  authorized,  issued and fully paid and
non-assessable.

3.7 Upon a conversion hereunder the Company shall not be required to issue stock
certificates  representing fractions of any Conversion Shares, and the number of
Conversion Shares shall be rounded up or down to the nearest whole number.

3.8 If the Company, at any time while this Note is outstanding: (A) pays a stock
dividend or otherwise  makes a distribution  or  distributions  in shares of its
Common  Stock or any other  equity or equity  equivalent  securities  payable in
shares of Common Stock, (B) subdivides outstanding shares of Common Stock into a
larger number of shares, (C) combines  (including by way of reverse stock split)
outstanding  shares of Common  Stock  into a smaller  number of  shares,  or (D)
issues by  reclassification  of shares of the Common Stock any shares of capital
stock of the  Company,  then the  Conversion  Price  shall  be  multiplied  by a
fraction of which the  numerator  shall be the number of shares of Common  Stock
(excluding  treasury shares, if any) outstanding  before such event and of which
the denominator  shall be the number of shares of Common Stock outstanding after
such event.  Any adjustment made pursuant to this Section shall become effective
immediately after the record date for the determination of stockholders entitled
to receive such dividend or distribution and shall become effective  immediately
after  the  effective  date  in  the  case  of  a  subdivision,  combination  or
re-classification.

4. REPAYMENT.

4.1 Repayment of this Note, including all interest, shall be due on the Maturity
Date, unless earlier converted into common shares.

                                       11
<PAGE>
5. INTEREST.

5.1 Interest on the Principal  Amount shall be calculated at 10%, per annum, and
be payable on May 18th of each year that the Note remains outstanding.

6. NOTICES.

6.1 Any and all notices or other  communications or deliveries to be provided by
the Holder hereunder,  including,  without limitation, any Notice of Conversion,
shall be in writing and delivered personally, by facsimile, sent by a nationally
recognized  overnight courier service,  addressed to the Company, at the address
set forth above,  or such other  address or facsimile  number as the Company may
specify for such purposes by notice to the Holder  delivered in accordance  with
this Section.  Any and all notices or other  communications  or deliveries to be
provided by the Company hereunder shall be in writing and delivered  personally,
by  facsimile,  sent  by  a  nationally  recognized  overnight  courier  service
addressed  to the Holder at the  facsimile  telephone  number or address of such
Holder appearing on the books of the Company,  or if no such facsimile telephone
number or address  appears,  at the address of the Holder to which this Note was
delivered.  Any notice or other  communication or deliveries  hereunder shall be
deemed given and effective on the earliest of (i) the date of  transmission,  if
such  notice or  communication  is  delivered  via  facsimile  at the  facsimile
telephone number specified in this Section prior to 5:30 p.m.  (Eastern Standard
Time),  (ii)  the  date  after  the  date of  transmission,  if such  notice  or
communication  is delivered  via  facsimile at the  facsimile  telephone  number
specified in this Section later than 5:30 p.m.  (Eastern  Standard  Time) on any
date and earlier than 11:59 p.m. (Eastern Standard Time) on such date, (iii) the
second  business  day  following  the  date of  mailing,  if sent by  nationally
recognized  overnight courier service,  or (iv) upon actual receipt by the party
to whom such notice is required to be given.

7. DEFINITIONS.

7.1 For the purposes hereof,  in addition to the terms defined elsewhere in this
Note: (i) capitalized terms not otherwise defined herein have the meanings given
to such terms in the Subscription Agreement,  and (ii) the following terms shall
have the following meanings:

     (a)  "BUSINESS DAY" means any day except Saturday, Sunday and any day which
          shall be a federal  legal  holiday  in the  United  States or a day on
          which banking  institutions  in the State of Florida are authorized or
          required by law or other government action to close.

     (b)  "COMMON STOCK" means the common stock,  par value $0.001 per share, of
          the  Company  and stock of any other  class into which such shares may
          hereafter have been reclassified or changed.

     (c)  "CONVERSION DATE" has the meaning set forth in Section 3.5 hereof.

     (d)  "CONVERSION PRICE" has the meaning set forth in Section 3.4 hereof.

     (e)  "CONVERSION  SHARE"  means shares of the  Company's  Common Stock into
          which  principal  and  Interest  due  pursuant  to  this  Note  may be
          converted.

     (f)  "EXCHANGE ACT" means the Securities Exchange Act of 1934, as amended.

     (g)  "FINANCING  DATE"  means  the date on which  the  Principal  Amount is
          delivered to the Company by the Investor.

     (h)  "SECURITIES ACT" means the Securities Act of 1933, as amended, and the
          rules and regulations promulgated thereunder.

     (i)  "TRADING  DAY"  means a day on which the  shares  of Common  Stock are
          traded on a trading  market  on which the  shares of Common  Stock are
          then listed or quoted,  provided, that in the event that the shares of
          Common  Stock are not listed or quoted,  then Trading Day shall mean a
          Business Day.

                                       12
<PAGE>
8. REPLACEMENT OF NOTE IF LOST OR DESTROYED.

If this Note shall be mutilated,  lost,  stolen or destroyed,  the Company shall
execute and deliver, in exchange and substitution for and upon cancellation of a
mutilated Note, or in lieu of or in substitution for a lost, stolen or destroyed
Note,  a new Note for the  principal  amount  of this Note so  mutilated,  lost,
stolen or  destroyed  but only upon  receipt of evidence of such loss,  theft or
destruction  of such  Note,  and of the  ownership  hereof,  and  indemnity,  if
requested, all reasonably satisfactory to the Company.

9. GOVERNING LAW.

All  questions   concerning  the   construction,   validity,   enforcement   and
interpretation  of this Note shall be governed by and  construed and enforced in
accordance with the internal laws of the State of Florida, without regard to the
principles of conflicts of law thereof.

10. WAIVERS.

Any waiver by the  Company or the  Holder of a breach of any  provision  of this
Note shall not operate as or be  construed to be a waiver of any other breach of
such provision or of any breach of any other provision of this Note. The failure
of the Company or the Holder to insist upon strict adherence to any term of this
Note on one or more  occasions  shall not be considered a waiver or deprive that
party of the right  thereafter  to insist upon strict  adherence to that term or
any other term of this Note. Any waiver must be in writing.

11. USURY.

If any provision of this Note is invalid, illegal or unenforceable,  the balance
of this Note shall remain in effect, and if any provision is inapplicable to any
Person or circumstance,  it shall  nevertheless  remain  applicable to all other
Persons  and  circumstances.  If it shall be found  that any  interest  or other
amount deemed interest due hereunder  violates  applicable laws governing usury,
the applicable rate of interest due hereunder shall  automatically be lowered to
equal the maximum  permitted  rate of interest.  The Company  covenants  (to the
extent that it may  lawfully  do so) that it shall not at any time insist  upon,
plead,  or in any manner  whatsoever  claim or take the benefit or advantage of,
any stay,  extension  or usury law or other law which would  prohibit or forgive
the Company  from paying all or any portion of the  principal  of or interest on
this Note as contemplated herein, wherever enacted, now or at any time hereafter
in  force,  or  which  may  affect  the  covenants  or the  performance  of this
indenture,  and the  Company  (to  the  extent  it may  lawfully  do so)  hereby
expressly  waives all benefits or advantage of any such law, and covenants  that
it will not, by resort to any such law,  hinder,  delay or impeded the execution
of any power  herein  granted  to the  Holder,  but will  suffer  and permit the
execution of every such as though no such law has been enacted.

                                       13
<PAGE>
12. NEXT BUSINESS DAY.

Whenever any payment or other  obligation  hereunder shall be due on a day other
than a Business Day, such payment shall be made on the next succeeding  Business
Day.

IN WITNESS  WHEREOF,  the Company has caused  this  Convertible  Note to be duly
executed by a duly authorized officer as of the date first above indicated.

                                        GURU HEALTH INC.

                                        By: /s/ Matthew Christopherson
                                            ------------------------------------
                                            Matthew Christopherson
                                        Title: President

                                       14
<PAGE>
                                     ANNEX A

                              NOTICE OF CONVERSION

The undersigned hereby elects to convert principal under the Convertible Note of
Guru Health Inc., a Nevada  corporation  (the  "COMPANY"),  due on May 18, 2014,
into  shares of the  Company's  common  stock  (each a  "Share")  as of the date
written below. The undersigned will pay all transfer taxes,  intangible or other
taxes payable with respect hereto and is delivering  herewith such  certificates
and opinions as reasonably requested by the Company in accordance therewith.  No
fee will be charged to the holder for any conversion.

The undersigned agrees to comply with the prospectus delivery requirements under
the applicable  securities laws in connection with any transfer of the aforesaid
Shares.

Conversion calculations:

Date to Effect Conversion:

Principal Amount of Note to be Converted:

Accrued Interest to be Converted:

Number of  Shares to be issued:

Signature:

Name:

Address:

                                       15
<PAGE>
                                     ANNEX B

                                  UNITED STATES
                        ACCREDITED INVESTOR QUESTIONNAIRE

All  capitalized  terms  herein,  unless  otherwise  defined,  have the meanings
ascribed thereto in the Subscription Agreement.

This  Questionnaire is for use by the Purchaser who is a US person (as that term
is defined  Regulation S of the United States  Securities Act of 1933 (the "1933
Act")) and has indicated an interest in purchasing Debentures of the Issuer. The
purpose of this  Questionnaire  is to assure the Issuer that the Purchaser  will
meet the  standards  imposed by the 1933 Act and the  appropriate  exemptions of
applicable  state  securities  laws.  The  Issuer  will rely on the  information
contained  in this  Questionnaire  for the purposes of such  determination.  The
Securities  will not be  registered  under  the 1933  Act in  reliance  upon the
exemption  from  registration  afforded by Section 3(b) and/or  Section 4(2) and
Regulation  D of the  1933  Act.  This  Questionnaire  is not  an  offer  of the
Securities  or any other  securities of the Issuer in any state other than those
specifically authorized by the Issuer.

All information contained in this Questionnaire will be treated as confidential.
However,  by signing and returning this  Questionnaire,  each  Purchaser  agrees
that, if necessary,  this  Questionnaire may be presented to such parties as the
Issuer deems  appropriate to establish the  availability,  under the 1933 Act or
applicable  state  securities law, of exemption from  registration in connection
with the sale of the Securities hereunder.

The Purchaser covenants, represents and warrants to the Issuer that it satisfies
one or  more  of  the  categories  of  "Accredited  Investors",  as  defined  by
Regulation D  promulgated  under the 1933 Act, as adjusted by Section 413 of the
Dodd-Frank  Wall Street  Reform  Consumer  Protection  Act, as indicated  below:
(Please initial in the space provide those categories, if any, of an "Accredited
Investor" which the Purchaser satisfies.)

         Category 1   An  organization  described  in Section  501(c)(3)  of the
---------             United  States  Internal  Revenue Code, a  corporation,  a
                      Massachusetts  or similar  business trust or  partnership,
                      not  formed for the  specific  purpose  of  acquiring  the
                      Securities, with total assets in excess of US $5,000,000.

         Category 2   A natural person whose  individual net worth, or joint net
---------             worth with that person's  spouse,  on the date of purchase
                      exceeds  US  $1,000,000,   excluding  the  value  of  such
                      person's primary residence.

         Category 3   A natural person who had an individual income in excess of
---------             US $200,000 in each of the two most recent  years or joint
                      income with that person's  spouse in excess of US $300,000
                      in each of those years and has a reasonable expectation of
                      reaching the same income level in the current year.

         Category 4   A "bank" as defined  under  Section  (3)(a)(2) of the 1933
---------             Act or savings and loan  association or other  institution
                      as defined in Section 3(a)(5)(A) of the 1933 Act acting in
                      its  individual  or fiduciary  capacity;  a broker  dealer
                      registered  pursuant  to  Section  15  of  the  SECURITIES
                      EXCHANGE ACT OF 1934 (United States); an insurance company
                      as defined in Section 2(13) of the 1933 Act; an investment
                      company  registered  under the  INVESTMENT  COMPANY ACT OF
                      1940 (United States) or a business  development company as
                      defined in Section  2(a)(48) of such Act; a Small Business
                      Investment  Company  licensed by the U.S.  Small  Business
                      Administration  under  Section  301(c) or (d) of the SMALL
                      BUSINESS  INVESTMENT ACT OF 1958 (United  States);  a plan
                      with total assets in excess of $5,000,000  established and
                      maintained by a state, a political subdivision thereof, or
                      an agency  or  instrumentality  of a state or a  political
                      subdivision thereof, for the benefit of its employees;  an
                      employee  benefit  plan within the meaning of the EMPLOYEE
                      RETIREMENT  INCOME  SECURITY ACT OF 1974  (United  States)
                      whose  investment  decisions are made by a plan fiduciary,
                      as defined in Section 3(21) of such Act, which is either a

                                       16
<PAGE>
                      bank,  savings and loan association,  insurance company or
                      registered  investment adviser, or if the employee benefit
                      plan has total  assets in excess of  $5,000,000,  or, if a
                      self-directed  plan, whose  investment  decisions are made
                      solely by persons that are accredited investors.

         Category 5   A private  business  development  company  as  defined  in
---------             Section 202(a)(22) of the INVESTMENT  ADVISERS ACT OF 1940
                      (United States).

         Category 6   A director or executive officer of the Issuer.
---------

         Category 7   A trust with  total  assets in excess of  $5,000,000,  not
---------             formed  for  the  specific   purpose  of   acquiring   the
                      Securities,  whose purchase is directed by a sophisticated
                      person as described in Rule  506(b)(2)(ii)  under the 1933
                      Act.

         Category 8   An entity in which all of the equity  owners  satisfy  the
---------             requirements of one or more of the foregoing categories.

Note that prospective  Purchaser claiming to satisfy one of the above categories
of  Accredited  Investor  may be  required  to supply the Issuer  with a balance
sheet,   prior  years'   federal   income  tax  returns  or  other   appropriate
documentation to verify and substantiate the Purchaser's status as an Accredited
Investor.

If the Purchaser is an entity which  initialled  Category 8 in reliance upon the
Accredited Investor  categories above, state the name,  address,  total personal
income  from all  sources  for the  previous  calendar  year,  and the net worth
(exclusive of home, home  furnishings and personal  automobiles) for each equity
owner of the said entity:

--------------------------------------------------------------------------------

The  Purchaser  hereby   certifies  that  the  information   contained  in  this
Questionnaire  is complete and accurate and the Purchaser will notify the Issuer
promptly of any change in any such information.  If this  Questionnaire is being
completed on behalf of a corporation,  partnership,  trust or estate, the person
executing on behalf of the  Purchaser  represents  that it has the  authority to
execute and deliver this Questionnaire on behalf of such entity.

IN WITNESS  WHEREOF,  the undersigned has executed this  Questionnaire as of the
___ day of _______________, 2012.

IF A CORPORATION, PARTNERSHIP OR          IF AN INDIVIDUAL:
OTHER ENTITY:

------------------------------------      --------------------------------------
PRINT NAME OF PURCHASER/DISCLOSED         PRINT NAME OF PURCHASER/DISCLOSED
PRINCIPAL                                 PRINCIPAL

------------------------------------      --------------------------------------
SIGNATURE OF AUTHORIZED SIGNATORY         SIGNATURE

------------------------------------      --------------------------------------
NAME AND POSITION OF AUTHORIZED           REPRESENTATIVE CAPACITY, IF APPLICABLE
SIGNATORY

------------------------------------      --------------------------------------
JURISDICTION OF RESIDENCE OF              JURISDICTION OF RESIDENCE OF
PURCHASER/DISCLOSED PRINCIPAL             PURCHASER/DISCLOSED PRINCIPAL

                                       17Exhibit 4.3

                           DOMARK INTERNATIONAL, INC.

         AMENDED 2012 STOCK PLAN FOR DIRECTORS, OFFICERS AND CONSULTANTS

SECTION 1. PURPOSE OF THE PLAN.

The purpose of the 2012 Stock Plan for Directors,  Officers and Consultants (the
"Plan")  is to  enhance  the  ability of Domark  International,  Inc.,  a Nevada
corporation  (the  "Company"),  to  attract  and  retain  highly  qualified  and
experienced  directors,  employees and  consultants  and to give such directors,
employees and consultants a continued proprietary interest in the success of the
Company.  In  addition,  the Plan is intended to  encourage  ownership of common
stock of the Company by the directors,  employees and consultants of the Company
and its  Affiliates (as defined  below) and to provide  increased  incentive for
such persons to render  services and to exert maximum  effort for the success of
the Company's business.

The  Plan  provides  eligible  employees  and  consultants  the  opportunity  to
participate in the  enhancement of shareholder  value by the grants of warrants,
options,  restricted  common  or  convertible  preferred  stock  if, as and when
preferred stock is authorized by the Company and its shareholders,  unrestricted
common or  convertible  preferred  stock and other awards under this Plan and to
have their bonuses and/or consulting fees payable in warrants, restricted common
or convertible  preferred stock,  unrestricted  common or convertible  preferred
stock and other awards, or any combination thereof.

In  addition,  the Company  expects that the Plan will  further  strengthen  the
identification   of  the   directors,   employees  and   consultants   with  the
stockholders.  Certain  options and  warrants to be granted  under this Plan are
intended to qualify as Incentive Stock Options ("ISOs")  pursuant to Section 422
of the Internal Revenue Code of 1986, as amended  ("Code"),  while other options
and warrants and preferred  stock  granted under this Plan will be  nonqualified
options or warrants  which are not  intended  to qualify as ISOs  ("Nonqualified
Options"),  either or both as provided in the agreements  evidencing the options
or warrants  described  in Section 5 hereof and shares of  preferred  stock,  as
provided in the designation  described in Section 7. Employees,  consultants and
directors who  participate  or become  eligible to participate in this Plan from
time to time are referred to collectively  herein as "Participants".  As used in
this Plan, the term "Affiliates"  means any "parent  corporation" of the Company
and any  "subsidiary  corporation"  of the  Company  within the  meaning of Code
Sections 424(e) and (f), respectively.

SECTION 2. ADMINISTRATION OF THE PLAN.

(a)  Composition of Committee.  The Plan shall be  administered  by the Board of
Directors of the Company  (the  "Board") or to a committee of the Board to which
responsibility  for the  administration of this Plan has been assigned on behalf
of the Board.  When acting in such capacity,  the Board is herein referred to as
the  "Committee,"  and in such case, the Board shall also designate the Chairman
of the Committee.

(b) Committee  Action.  The Committee  shall hold its meetings at such times and
places as it may determine. A majority of its members shall constitute a quorum,
and all  determinations  of the  Committee  shall  be made  by not  less  than a
<PAGE>
majority of its members.  Any decision or  determination  reduced to writing and
signed by a majority of the members  shall be fully  effective as if it had been
made by a majority  vote of its members at a meeting  duly called and held.  The
Committee may designate the Secretary of the Company or other Company  employees
to  assist  the  Committee  in the  administration  of the  Plan,  and may grant
authority  to such persons to execute  award  agreements  or other  documents on
behalf of the Committee and the Company.  Any duly constituted  committee of the
Board  satisfying the  qualifications  of this Section 2 may be appointed as the
Committee.

(c) Committee Expenses.  All expenses and liabilities  incurred by the Committee
in the  administration of the Plan shall be borne by the Company.  The Committee
may employ attorneys, consultants, accountants or other persons.

SECTION 3. STOCK RESERVED FOR THE PLAN.

Subject to adjustment as provided in Section  5(d)(xiii)  hereof,  the aggregate
number of shares that may be optioned, subject to conversion or issued under the
Plan is 1,500,000 shares of common stock, warrants,  options, preferred stock or
any  combination  thereof.  The  shares  subject  to the Plan  shall  consist of
authorized  but unissued  shares of common stock and such number of shares shall
be and is hereby  reserved for sale for such  purpose.  Any of such shares which
may  remain  unsold and which are not  subject  to  issuance  upon  exercise  of
outstanding options or warrants or conversion of outstanding shares of preferred
stock at the  termination of the Plan shall cease to be reserved for the purpose
of the Plan, but until termination of the Plan or the termination of the last of
the options or warrants  granted  under the Plan,  whichever  last  occurs,  the
Company  shall at all times  reserve a  sufficient  number of shares to meet the
requirements  of the Plan.  Should any option or warrant  expire or be cancelled
prior to its exercise in full, the shares theretofore  subject to such option or
warrant may again be made subject to an option, warrant or shares of convertible
preferred stock under the Plan.

SECTION 4. ELIGIBILITY.

The Participants shall include directors,  employees, including officers, of the
Company and its divisions and  subsidiaries,  and  consultants and attorneys who
provide  bona fide  services to the  Company.  Participants  are  eligible to be
granted warrants,  options,  restricted  common or convertible  preferred stock,
unrestricted  common or convertible  preferred stock and other awards under this
Plan and to have their  bonuses  and/or  consulting  fees  payable in  warrants,
restricted  common  or  convertible  preferred  stock,  unrestricted  common  or
convertible preferred stock and other awards. A Participant who has been granted
an option,  warrant or preferred  stock  hereunder  may be granted an additional
option, warrant options,  warrants or preferred stock, if the Committee shall so
determine.

SECTION 5. GRANT OF OPTIONS OR WARRANTS.

(a)  Committee   Discretion.   The  Committee   shall  have  sole  and  absolute
discretionary authority (i) to determine, authorize, and designate those persons
pursuant to this Plan who are to receive warrants, options, restricted common or
convertible  preferred  stock, or unrestricted  common or convertible  preferred
stock under the Plan,  (ii) to determine the number of shares of common stock to
be covered by such grant or such  options  or  warrants  and the terms  thereof,
(iii) to  determine  the type of  common  stock  granted:  restricted  common or
convertible preferred stock,  unrestricted common or convertible preferred stock

                                       2
<PAGE>
or a combination of restricted and unrestricted common or convertible  preferred
stock,  and (iv) to  determine  the type of  option  or  warrant  granted:  ISO,
Nonqualified  Option  or a  combination  of ISO and  Nonqualified  Options.  The
Committee  shall  thereupon  grant options or warrants in  accordance  with such
determinations as evidenced by a written option or warrant agreement. Subject to
the express  provisions  of the Plan,  the  Committee  shall have  discretionary
authority to prescribe,  amend and rescind rules and regulations relating to the
Plan,  to interpret  the Plan, to prescribe and amend the terms of the option or
warrant  agreements  (which  need  not be  identical)  and  to  make  all  other
determinations deemed necessary or advisable for the administration of the Plan.

(b) Stockholder  Approval.  All ISOs granted under this Plan are subject to, and
may not be exercised before, the approval of this Plan by the stockholders prior
to the first  anniversary date of the Board meeting held to approve the Plan, by
the affirmative  vote of the holders of a majority of the outstanding  shares of
the  Company  present,  or  represented  by proxy,  and  entitled to vote at the
meeting,  or by  written  consent  in  accordance  with the laws of the State of
Florida,  provided that if such approval by the  stockholders  of the Company is
not  forthcoming,  all options or warrants and stock awards  previously  granted
under this Plan other than ISOs shall be valid in all respects.

(c)  Limitation  on Incentive  Stock Options and  Warrants.  The aggregate  fair
market value (determined in accordance with Section 5(d)(ii) of this Plan at the
time the option or warrant is granted) of the common stock with respect to which
ISOs  may be  exercisable  for the  first  time by any  Participant  during  any
calendar year under all such plans of the Company and its  Affiliates  shall not
exceed $25,000,000.

(d) Terms and Conditions. Each option or warrant granted under the Plan shall be
evidenced by an agreement,  in a form approved by the Committee,  which shall be
subject to the following  express terms and  conditions  and to such other terms
and conditions as the Committee may deem appropriate:

     (i) Option or Warrant  Period.  The  Committee  shall  promptly  notify the
Participant  of the  option  or  warrant  grant and a  written  agreement  shall
promptly  be  executed  and  delivered  by and on behalf of the  Company and the
Participant, provided that the option or warrant grant shall expire if a written
agreement is not signed by said  Participant  (or his agent) and returned to the
Company  within  60  days  from  date  of  receipt  by the  Participant  of such
agreement. The date of grant shall be the date the option or warrant is actually
granted by the Committee,  even though the written agreement may be executed and
delivered  by the Company and the  Participant  after that date.  Each option or
warrant  agreement  shall  specify  the  period  for which the option or warrant
thereunder is granted (which in no event shall exceed ten years from the date of
grant) and shall  provide that the option or warrant  shall expire at the end of
such period. If the original term of an option or warrant is less than ten years
from the date of  grant,  the  option or  warrant  may be  amended  prior to its
expiration,  with the approval of the Committee and the  Participant,  to extend
the term so that the term as amended is not more than ten years from the date of
the original grant. However, in the case of an ISO granted to an individual who,
at the time of grant,  owns stock  possessing  more than 10 percent of the total
combined  voting  power of all classes of stock of the Company or its  Affiliate
("Ten  Percent  Stockholder"),  such period shall not exceed five years from the
date of grant.

     (ii) Option or Warrant  Price.  The purchase  price of each share of common
stock  subject to each option or warrant  granted  pursuant to the Plan shall be
determined by the Committee at the time the option or warrant is granted and, in

                                       3
<PAGE>
the case of ISOs,  shall  not be less than  100% of the fair  market  value of a
share of  common  stock on the  date  the  option  or  warrant  is  granted,  as
determined  by the  Committee.  In the case of an ISO  granted to a Ten  Percent
Stockholder, the option or warrant price shall not be less than 110% of the fair
market  value of a share of common  stock on the date the  option or  warrant is
granted.  The  purchase  price  of each  share  of  common  stock  subject  to a
Nonqualified  Option or  Warrant  under  this Plan  shall be  determined  by the
Committee  prior to granting the option or warrant.  The Committee shall set the
purchase  price for each share  subject to a  Nonqualified  Option or Warrant at
either the fair market  value of each share on the date the option or warrant is
granted,  or at such other price as the Committee in its sole  discretion  shall
determine.

At the time a determination  of the fair market value of a share of common stock
is required to be made  hereunder,  the  determination  of its fair market value
shall be made by the Committee in such manner as it deems appropriate.

     (iii) Exercise  Period.  The Committee may provide in the option or warrant
agreement that an option or warrant may be exercised in whole,  immediately,  or
is to be exercisable in increments.  In addition, the Committee may provide that
the  exercise  of all or part of an option or warrant  is  subject to  specified
performance by the Participant.

     (iv) Procedure for Exercise.  Options or warrants shall be exercised in the
manner  specified  in the option or warrant  agreement.  The notice of  exercise
shall  specify the address to which the  certificates  for such shares are to be
mailed. A Participant shall be deemed to be a stockholder with respect to shares
covered by an option or warrant on the date  specified  in the option or warrant
agreement.  As  promptly  as  practicable,  the  Company  shall  deliver  to the
Participant  or other  holder of the  warrant,  certificates  for the  number of
shares  with  respect to which such  option or  warrant  has been so  exercised,
issued in the holder's name or such other name as the holder directs;  provided,
however,  that such  delivery  shall be deemed  effected for all purposes when a
stock transfer agent of the Company shall have deposited such  certificates with
a carrier  for  overnight  delivery,  addressed  to the  holder  at the  address
specified  pursuant to this Section  6(d).  The proceeds  from any such exercise
shall be added to the general funds of the Company and shall be used for general
corporate purposes.

     (v) Termination of Employment. If an executive officer to whom an option or
warrant is granted  ceases to be employed  by the  Company for any reason  other
than death or disability, any option or warrant which is exercisable on the date
of such  termination of employment may be exercised during a period beginning on
such date and ending at the time set forth in the  option or warrant  agreement;
provided,  however, that if a Participant's  employment is terminated because of
the Participant's  theft or embezzlement  from the Company,  disclosure of trade
secrets of the Company or the  commission  of a willful,  felonious act while in
the employment of the Company (such reasons shall  hereinafter  be  collectively
referred to as "for cause"),  then any option or warrant or unexercised  portion
thereof  granted to said  Participant  shall  expire  upon such  termination  of
employment.  Notwithstanding  the foregoing,  no ISO may be exercised later than
three months after an employee's  termination of employment for any reason other
than death or disability.

     (vi) Disability or Death of Participant.  In the event of the determination
of  disability  or  death of a  Participant  under  the Plan  while he or she is
employed by the Company,  the options or warrants  previously granted to him may
be exercised  (to the extent he or she would have been  entitled to do so at the

                                       4
<PAGE>
date of the  determination  of disability or death) at any time and from time to
time, within a period beginning on the date of such  determination of disability
or death and ending at the time set forth in the option or warrant agreement, by
the former employee,  the guardian of his estate,  the executor or administrator
of his estate or by the person or persons to whom his rights under the option or
warrant  shall pass by will or the laws of descent and  distribution,  but in no
event may the option or  warrant be  exercised  after its  expiration  under the
terms of the option or warrant agreement.  Notwithstanding the foregoing, no ISO
may be exercised  later than one year after the  determination  of disability or
death.  A  Participant  shall be deemed to be  disabled  if, in the opinion of a
physician  selected  by the  Committee,  he or she is  incapable  of  performing
services  for the Company of the kind he or she was  performing  at the time the
disability occurred by reason of any medically  determinable  physical or mental
impairment which can be expected to result in death or to be of long,  continued
and indefinite  duration.  The date of  determination of disability for purposes
hereof shall be the date of such determination by such physician.

     (vii) Assignability.  An option or warrant shall be assignable or otherwise
transferable,  in whole or in part, by a Participant  as provided in the option,
warrant or designation of the series of preferred stock.

     (viii)  Incentive  Stock  Options.  Each  option or warrant  agreement  may
contain such terms and provisions as the Committee may determine to be necessary
or desirable in order to qualify an option or warrant designated as an incentive
stock option.

     (ix) Restricted  Stock Awards.  Awards of restricted  stock under this Plan
shall be subject to all the  applicable  provisions of this Plan,  including the
following  terms and  conditions,  and to such other  terms and  conditions  not
inconsistent therewith, as the Committee shall determine:

     (A) Awards of  restricted  stock may be in addition to or in lieu of option
or warrant  grants.  Awards may be  conditioned  on the attainment of particular
performance goals based on criteria  established by the Committee at the time of
each award of restricted stock.  During a period set forth in the agreement (the
"Restriction  Period"),  the recipient shall not be permitted to sell, transfer,
pledge, or otherwise  encumber the shares of restricted stock;  except that such
shares may be used, if the agreement permits, to pay the option or warrant price
pursuant  to any option or warrant  granted  under this Plan,  provided an equal
number of shares delivered to the Participant  shall carry the same restrictions
as the shares so used.  Shares of  restricted  stock  shall  become  free of all
restrictions if during the Restriction  Period, (i) the recipient dies, (ii) the
recipient's  directorship,  employment,  or consultancy  terminates by reason of
permanent  disability,  as  determined  by the  Committee,  (iii) the  recipient
retires  after  attaining  both 59 1/2 years of age and five years of continuous
service with the Company and/or a division or subsidiary, or (iv) if provided in
the agreement, there is a "change in control" of the Company (as defined in such
agreement).  The Committee may require medical evidence of permanent disability,
including medical  examinations by physicians  selected by it. Unless and to the
extent otherwise provided in the agreement,  shares of restricted stock shall be
forfeited  and  revert  to the  Company  upon  the  recipient's  termination  of
directorship,  employment or consultancy  during the Restriction  Period for any
reason other than death,  permanent disability,  as determined by the Committee,
retirement after attaining both 59 1/2 years of age and five years of continuous
service  with the Company  and/or a subsidiary  or  division,  or, to the extent
provided in the  agreement,  a "change in control" of the Company (as defined in
such  agreement),  except to the extent the Committee,  in its sole  discretion,
finds that such  forfeiture  might not be in the best  interests  of the Company
and,  therefore,  waives all or part of the application of this provision to the

                                       5
<PAGE>
restricted stock held by such recipient. Certificates for restricted stock shall
be  registered  in the name of the  recipient  but shall be  imprinted  with the
appropriate legend and returned to the Company by the recipient, together with a
stock power endorsed in blank by the recipient.  The recipient shall be entitled
to vote shares of restricted  stock and shall be entitled to all dividends  paid
thereon, except that dividends paid in common stock or other property shall also
be subject to the same restrictions.

     (B) Restricted Stock shall become free of the foregoing  restrictions  upon
expiration  of the  applicable  Restriction  Period and the  Company  shall then
deliver to the recipient common stock certificates  evidencing such unrestricted
stock.

Restricted  stock and any  common  stock  received  upon the  expiration  of the
restriction period shall be subject to such other transfer  restrictions  and/or
legend requirements as are specified in the applicable agreement.

     (x) Bonuses and Past Salaries and Fees Payable in Unrestricted Stock.

     (A) In lieu of cash  bonuses  otherwise  payable  under  the  Company's  or
applicable  division's or subsidiary's  compensation  practices to employees and
consultants  eligible to participate  in this Plan,  the Committee,  in its sole
discretion,  may determine  that such bonuses  shall be payable in  unrestricted
common stock or partly in  unrestricted  common  stock and partly in cash.  Such
bonuses shall be in  consideration  of services  previously  performed and as an
incentive  toward future  services and shall  consist of shares of  unrestricted
common stock  subject to such terms as the  Committee  may determine in its sole
discretion. The number of shares of unrestricted common stock payable in lieu of
a bonus  otherwise  payable shall be determined by dividing such bonus amount by
the fair  market  value of one  share of  common  stock on the date the bonus is
payable,  with fair market value  determined as of such date in accordance  with
Section 5(d)(ii).

     (B) In lieu of  salaries  and fees  otherwise  payable  by the  Company  to
employees,  attorneys and consultants  eligible to participate in this Plan that
were incurred for services rendered, the Committee, in its sole discretion,  may
determine  that such unpaid  salaries and fees shall be payable in  unrestricted
common stock or partly in  unrestricted  common  stock and partly in cash.  Such
awards shall be in  consideration  of services  previously  performed  and as an
incentive  toward future  services and shall  consist of shares of  unrestricted
common stock  subject to such terms as the  Committee  may determine in its sole
discretion. The number of shares of unrestricted common stock payable in lieu of
salaries  and fees  otherwise  payable  shall be  determined  by  dividing  each
calendar  month's of unpaid salary or fee amount by the average trading value of
the common stock for the calendar  month during which the subject  services were
provided.

     (xi) No Rights as  Stockholder.  No Participant  shall have any rights as a
stockholder  with  respect to shares  covered by an option or warrant  until the
option or warrant is exercised as provided in clause (d) above.

     (xii) Extraordinary  Corporate  Transactions.  The existence of outstanding
options  or  warrants  shall  not  affect  in any way the  right or power of the
Company  or its  stockholders  to  make  or  authorize  any or all  adjustments,
recapitalizations, reorganizations, exchanges, or other changes in the Company's
capital  structure  or its  business,  or any  merger  or  consolidation  of the
Company,  or any issuance of common stock or other  securities  or  subscription
rights  thereto,  or any  issuance  of  bonds,  debentures,  preferred  or prior
preference  stock ahead of or affecting the common stock or the rights  thereof,

                                       6
<PAGE>
or the dissolution or liquidation of the Company, or any sale or transfer of all
or any part of its assets or business, or any other corporate act or proceeding,
whether of a similar  character or otherwise.  If the Company  recapitalizes  or
otherwise changes its capital structure, or merges,  consolidates,  sells all of
its assets or dissolves  (each of the foregoing a  "Fundamental  Change"),  then
thereafter  upon any  exercise of an option or warrant  theretofore  granted the
Participant shall be entitled to purchase under such option or warrant,  in lieu
of the number of shares of common stock as to which option or warrant shall then
be exercisable,  the number and class of shares of stock and securities to which
the  Participant  would  have  been  entitled  pursuant  to  the  terms  of  the
Fundamental  Change  if,  immediately  prior  to such  Fundamental  Change,  the
Participant  had been the  holder of  record  of the  number of shares of common
stock as to which such option or warrant is then exercisable. If (i) the Company
shall not be the surviving  entity in any merger or  consolidation  (or survives
only  as a  subsidiary  of  another  entity),  (ii)  the  Company  sells  all or
substantially  all of its  assets to any other  person or entity  (other  than a
wholly-owned  subsidiary),  (iii) any person or entity  (including  a "group" as
contemplated  by  Section  13(d)(3)  of the  Exchange  Act)  acquires  or  gains
ownership or control of (including, without limitation, power to vote) more than
50% of the  outstanding  shares  of  common  stock,  (iv) the  Company  is to be
dissolved  and  liquidated,  or  (v)  as a  result  of or in  connection  with a
contested  election of directors,  the persons who were directors of the Company
before such  election  shall cease to  constitute  a majority of the Board (each
such  event in  clauses  (i)  through  (v)  above is  referred  to  herein  as a
"Corporate Change"), the Committee,  in its sole discretion,  may accelerate the
time at which all or a portion  of a  Participant's  option or  warrants  may be
exercised for a limited period of time before or after a specified date.

     (xiii) Changes in Company's Capital Structure. If the outstanding shares of
common stock or other  securities of the Company,  or both, for which the option
or  warrant  is  then  exercisable  at any  time  be  changed  or  exchanged  by
declaration  of  a  stock   dividend,   stock  split,   combination  of  shares,
recapitalization,  or  reorganization,  the  number and kind of shares of common
stock or other  securities  which  are  subject  to the Plan or  subject  to any
options or warrants theretofore granted, and the option or warrant prices, shall
be adjusted proportionally unless otherwise provided in the option or warrant.

     (xiv)  Acceleration  of  Options  and  Warrants.   Except  as  hereinbefore
expressly  provided,  (i) the  issuance by the Company of shares of stock or any
class of  securities  convertible  into shares of stock of any class,  for cash,
property,  labor or services,  upon direct sale,  upon the exercise of rights or
warrants to subscribe  therefor,  or upon conversion of shares or obligations of
the Company  convertible into such shares or other securities,  (ii) the payment
of a dividend in property other than common stock or (iii) the occurrence of any
similar  transaction,  and in any case whether or not for fair value,  shall not
affect,  and no adjustment by reason  thereof shall be made with respect to, the
number of shares of common  stock  subject to options  or  warrants  theretofore
granted or the purchase price per share,  unless the Committee shall  determine,
in its sole  discretion,  that an adjustment  is necessary to provide  equitable
treatment to a Participant.  Notwithstanding  anything to the contrary contained
in this Plan, the Committee may, in its sole discretion,  accelerate the time at
which any option or warrant  may be  exercised,  including,  but not limited to,
upon the occurrence of the events specified in this Section 5, and is authorized
at any time  (with the  consent  of the  Participant)  to  purchase  options  or
warrants pursuant to Section 6.

                                       7
<PAGE>
SECTION 6.  RELINQUISHMENT OF OPTIONS OR WARRANTS.

(a) The  Committee,  in  granting  options  or  warrants  hereunder,  shall have
discretion to determine whether or not options or warrants shall include a right
of relinquishment as hereinafter provided by this Section 6. The Committee shall
also have  discretion  to  determine  whether  an option  or  warrant  agreement
evidencing an option or warrant  initially  granted by the  Committee  without a
right of relinquishment shall be amended or supplemented to include such a right
of  relinquishment.  Neither the  Committee  nor the Company  shall be under any
obligation  or incur any  liability  to any person by reason of the  Committee's
refusal to grant or include a right of  relinquishment  in any option or warrant
granted  hereunder or in any option or warrant  agreement  evidencing  the same.
Subject to the Committee's  determination  in any case that the grant by it of a
right of  relinquishment  is  consistent  with  Section 1 hereof,  any option or
warrant granted under this Plan, and the option or warrant agreement  evidencing
such option or warrant, may provide:

     (i)  That  the   Participant,   or  his  or  her   heirs  or  other   legal
representatives  to the extent  entitled to exercise the option or warrant under
the terms thereof,  in lieu of purchasing the entire number of shares subject to
purchase  thereunder,  shall have the right to relinquish all or any part of the
then  unexercised  portion  of  the  option  or  warrant  (to  the  extent  then
exercisable)  for a  number  of  shares  of  common  stock to be  determined  in
accordance with the following provisions of this clause (i):

     (A) The written  notice of exercise of such right of  relinquishment  shall
state the  percentage  of the total  number of shares of common  stock  issuable
pursuant to such  relinquishment  (as defined below) that the Participant elects
to receive;

     (B) The number of shares of common stock, if any, issuable pursuant to such
relinquishment  shall be the number of such shares,  rounded to the next greater
number of full shares,  as shall be equal to the  quotient  obtained by dividing
(i) the  appreciated  alue by (ii) the  purchase  price for each of such  shares
specified in such option or warrant;

     (C) For the  purpose of this  clause  (C),  "appreciated  value"  means the
excess,  if any, of (x) the total  current  market value of the shares of common
stock covered by the option or warrant or the portion thereof to be relinquished
over (y) the total  purchase  price for such shares  specified in such option or
warrant;

     (ii) That such right of  relinquishment  may be exercised only upon receipt
by the Company of a written notice of such  relinquishment  which shall be dated
the date of election to make such relinquishment;  and that, for the purposes of
this Plan, such date of election shall be deemed to be the date when such notice
is sent by registered or certified  mail, or when receipt is acknowledged by the
Company, if mailed by other than registered or certified mail or if delivered by
hand or by any telegraphic  communications  equipment of the sender or otherwise
delivered;   provided,  that,  in  the  event  the  method  just  described  for
determining  such date of election  shall not be or remain  consistent  with the
provisions  of Section  16(b) of the Exchange  Act or the rules and  regulations
adopted  by  the  Commission  thereunder,  as  presently  existing  or as may be
hereafter amended,  which regulations exempt from the operation of Section 16(b)
of the  Exchange  Act in whole or in part any such  relinquishment  transaction,
then such date of election  shall be determined by such other method  consistent

                                       8
<PAGE>
with Section 16(b) of the Exchange Act or the rules and  regulations  thereunder
as the Committee shall in its discretion select and apply;

     (iii)  That the  "current  market  value" of a share of  common  stock on a
particular  date  shall be  deemed to be its fair  market  value on that date as
determined in accordance with Paragraph 5(d)(ii); and

     (iv)  That  the  option  or  warrant,  or  any  portion  thereof,   may  be
relinquished  only to the extent that (A) it is  exercisable on the date written
notice of relinquishment is received by the Company,  and (B) the holder of such
option or warrant pays, or makes  provision  satisfactory to the Company for the
payment of, any taxes which the Company is  obligated to collect with respect to
such relinquishment.

(b) The Committee  shall have sole  discretion to consent to or disapprove,  and
neither the  Committee nor the Company shall be under any liability by reason of
the  Committee's  disapproval of, any election by a holder of preferred stock to
relinquish  such  preferred  stock in whole or in part as provided in  Paragraph
7(a),  except that no such consent to or approval of a  relinquishment  shall be
required under the following  circumstances.  Each Participant who is subject to
the short-swing  profits  recapture  provisions of Section 16(b) of the Exchange
Act ("Covered  Participant")  shall not be entitled to receive  shares of common
stock when  options  or  warrants  are  relinquished  during  any window  period
commencing  on the third  business  day  following  the  Company's  release of a
quarterly  or annual  summary  statement of sales and earnings and ending on the
twelfth  business  day  following  such  release  ("Window  Period").  A Covered
Participant  shall be  entitled  to  receive  shares  of common  stock  upon the
relinquishment of options or warrants outside a Window Period.

(c) The  Committee,  in  granting  options  or  warrants  hereunder,  shall have
discretion to determine  the terms upon which such options or warrants  shall be
relinquishable, subject to the applicable provisions of this Plan, and including
such  provisions  as are  deemed  advisable  to permit  the  exemption  from the
operation  from Section  16(b) of the  Exchange  Act of any such  relinquishment
transaction,   and  options  or  warrants  outstanding,  and  option  agreements
evidencing such options, may be amended, if necessary, to permit such exemption.
If options or warrants are relinquished,  such option or warrant shall be deemed
to have been  exercised  to the extent of the  number of shares of common  stock
covered by the option or warrant or part thereof which is  relinquished,  and no
further options or warrants may be granted covering such shares of common stock.

(d) Any options or warrants or any right to  relinquish  the same to the Company
as  contemplated  by this  Paragraph 6 shall be assignable  by the  Participant,
provided the transaction complies with any applicable securities laws.

(e) Except as provided in Section 6(f) below, no right of relinquishment  may be
exercised  within the first six months after the initial  award of any option or
warrant  containing,  or the amendment or supplementation of any existing option
or warrant agreement adding, the right of relinquishment.

(f) No right of  relinquishment  may be exercised after the initial award of any
option  or  warrant  containing,  or the  amendment  or  supplementation  of any
existing option or warrant agreement adding the right of relinquishment,  unless
such  right  of  relinquishment  is  effective  upon  the  Participant's  death,
disability  or  termination  of his  relationship  with the Company for a reason
other than "for cause."

                                       9
<PAGE>
SECTION 7. GRANT OF CONVERTIBLE PREFERRED STOCK.

(a)  Committee   Discretion.   The  Committee   shall  have  sole  and  absolute
discretionary authority (i) to determine, authorize, and designate those persons
pursuant  to this  Plan  who  are to  receive  restricted  preferred  stock,  or
unrestricted preferred stock under the Plan, and (ii) to determine the number of
shares of common stock to be issued upon  conversion of such shares of preferred
stock and the terms  thereof.  The  Committee  shall  thereupon  grant shares of
preferred stock in accordance with such determinations as evidenced by a written
preferred stock designation.  Subject to the express provisions of the Plan, the
Committee  shall have  discretionary  authority to prescribe,  amend and rescind
rules and regulations  relating to the Plan, to interpret the Plan, to prescribe
and  amend the  terms of the  preferred  stock  designation  (which  need not be
identical) and to make all other  determinations  deemed  necessary or advisable
for the administration of the Plan.

(b) Terms and Conditions.  Each series of preferred stock granted under the Plan
shall be evidenced by a designation in the form for filing with the Secretary of
State of the state of  incorporation  of the Company,  containing  such terms as
approved by the Committee, which shall be subject to the following express terms
and  conditions and to such other terms and conditions as the Committee may deem
appropriate:

     (i)  Conversion  Ratio.  The number of shares of common stock issuable upon
conversion of each share of preferred  stock granted  pursuant to the Plan shall
be determined by the Committee at the time the preferred  stock is granted.  The
conversion ratio may be determined by reference to the fair market value of each
share of common  stock on the date the  preferred  stock is granted,  or at such
other price as the Committee in its sole discretion shall determine.

At the time a determination  of the fair market value of a share of common stock
is required to be made  hereunder,  the  determination  of its fair market value
shall be made in accordance with Paragraph 5(d)(ii).

     (ii)  Conversion  Period.  The Committee may provide in the preferred stock
agreement that the preferred  stock may be converted in whole  immediately or is
to be convertible in increments. In addition, the Committee may provide that the
conversion  of all or  part of the  preferred  stock  is  subject  to  specified
performance by the Participant.

     (iii)  Procedure  for  Conversion.  Shares  of  preferred  stock  shall  be
converted in the manner specified in the preferred stock designation. The notice
of  conversion  shall  specify  the address to which the  certificates  for such
shares are to be mailed. A Participant  shall be deemed to be a stockholder with
respect  to shares  covered  by  preferred  stock on the date  specified  in the
preferred stock agreement. As promptly as practicable, the Company shall deliver
to the Participant or other holder of the warrant,  certificates  for the number
of shares  with  respect to which such  preferred  stock has been so  converted,
issued in the  holder's  name or such  other name as holder  directs;  provided,
however,  that such  delivery  shall be deemed  effected for all purposes when a
stock transfer agent of the Company shall have deposited such  certificates with
a carrier  for  overnight  delivery,  addressed  to the  holder  at the  address
specified pursuant to this Section 6(d).

     (iv) Termination of Employment.  If an executive  officer to whom preferred
stock is granted  ceases to be employed by the Company for any reason other than
death or  disability,  any preferred  stock which is  convertible on the date of

                                       10
<PAGE>
such  termination  of employment may be converted  during a period  beginning on
such date and  ending at the time set forth in the  preferred  stock  agreement;
provided,  however, that if a Participant's  employment is terminated because of
the Participant's  theft or embezzlement  from the Company,  disclosure of trade
secrets of the Company or the  commission  of a willful,  felonious act while in
the employment of the Company (such reasons shall  hereinafter  be  collectively
referred to as "for cause"),  then any preferred  stock or  unconverted  portion
thereof  granted to said  Participant  shall  expire  upon such  termination  of
employment.  Notwithstanding  the foregoing,  no ISO may be converted later than
three months after an employee's  termination of employment for any reason other
than death or disability.

     (v) Disability or Death of Participant.  In the event of the  determination
of  disability  or  death of a  Participant  under  the Plan  while he or she is
employed by the Company,  the preferred stock  previously  granted to him may be
converted (to the extent he or she would have been entitled to do so at the date
of the  determination of disability or death) at any time and from time to time,
within a period  beginning on the date of such  determination  of  disability or
death and ending at the time set forth in the preferred stock agreement,  by the
former  employee,  the guardian of his estate,  the executor or administrator of
his estate or by the person or  persons to whom his rights  under the  preferred
stock  shall pass by will or the laws of  descent  and  distribution,  but in no
event may the preferred stock be converted after its expiration  under the terms
of the preferred stock agreement.  Notwithstanding the foregoing,  no ISO may be
converted later than one year after the  determination of disability or death. A
Participant  shall be deemed to be  disabled  if, in the  opinion of a physician
selected by the Committee, he or she is incapable of performing services for the
Company of the kind he or she was performing at the time the disability occurred
by reason of any medically  determinable physical or mental impairment which can
be  expected  to  result  in death or to be of long,  continued  and  indefinite
duration.  The date of  determination of disability for purposes hereof shall be
the date of such determination by such physician.

     (vi)  Assignability.  Preferred  stock  shall be  assignable  or  otherwise
transferable, in whole or in part, by a Participant.

     (vii) Restricted Stock Awards.  Awards of restricted  preferred stock under
this Plan  shall be  subject  to all the  applicable  provisions  of this  Plan,
including  the  following  terms and  conditions,  and to such  other  terms and
conditions not inconsistent therewith, as the Committee shall determine:

     (A) Awards of restricted  preferred  stock may be in addition to or in lieu
of preferred  stock  grants.  Awards may be  conditioned  on the  attainment  of
particular  performance goals based on criteria  established by the Committee at
the time of each award of restricted  preferred stock. During a period set forth
in  the  agreement  (the  "Restriction  Period"),  the  recipient  shall  not be
permitted  to sell,  transfer,  pledge,  or  otherwise  encumber  the  shares of
restricted  preferred stock.  Shares of restricted  preferred stock shall become
free of all  restrictions  if during the Restriction  Period,  (i) the recipient
dies, (ii) the recipient's  directorship,  employment, or consultancy terminates
by reason of permanent  disability,  as determined by the  Committee,  (iii) the
recipient  retires  after  attaining  both 59 1/2 years of age and five years of
continuous service with the Company and/or a division or subsidiary,  or (iv) if
provided  in the  agreement,  there is a "change in  control" of the Company (as
defined in such agreement).

The Committee may require medical  evidence of permanent  disability,  including
medical  examinations  by  physicians  selected by it.  Unless and to the extent
otherwise provided in the agreement,  shares of restricted preferred stock shall

                                       11
<PAGE>
be  forfeited  and revert to the Company  upon the  recipient's  termination  of
directorship,  employment or consultancy  during the Restriction  Period for any
reason other than death,  permanent disability,  as determined by the Committee,
retirement after attaining both 59 1/2 years of age and five years of continuous
service  with the Company  and/or a subsidiary  or  division,  or, to the extent
provided in the  agreement,  a "change in control" of the Company (as defined in
such  agreement),  except to the extent the Committee,  in its sole  discretion,
finds that such  forfeiture  might not be in the best  interests  of the Company
and,  therefore,  waives all or part of the application of this provision to the
restricted  preferred stock held by such recipient.  Certificates for restricted
preferred  stock shall be  registered  in the name of the recipient but shall be
imprinted  with the  appropriate  legend  and  returned  to the  Company  by the
recipient,  together  with a  preferred  stock  power  endorsed  in blank by the
recipient.  The  recipient  shall  be  entitled  to vote  shares  of  restricted
preferred stock and shall be entitled to all dividends paid thereon, except that
dividends  paid in common stock or other  property  shall also be subject to the
same restrictions.

     (B)  Restricted   preferred  stock  shall  become  free  of  the  foregoing
restrictions  upon  expiration  of the  applicable  Restriction  Period  and the
Company  shall  then  deliver  to the  recipient  preferred  stock  certificates
evidencing such stock.  Restricted preferred stock and any common stock received
upon the  expiration  of the  restriction  period shall be subject to such other
transfer  restrictions  and/or  legend  requirements  as  are  specified  in the
applicable agreement.

     (x) Bonuses and Past  Salaries and Fees Payable in  Unrestricted  Preferred
stock.

     (A) In lieu of cash  bonuses  otherwise  payable  under  the  Company's  or
applicable  division's or subsidiary's  compensation  practices to employees and
consultants  eligible to participate  in this Plan,  the Committee,  in its sole
discretion,  may determine  that such bonuses  shall be payable in  unrestricted
preferredstock  or partly in  unrestricted  preferred  stock and partly in cash.
Such bonuses shall be in consideration of services  previously  performed and as
an incentive  toward future services and shall consist of shares of unrestricted
preferred stock subject to such terms as the Committee may determine in its sole
discretion. The number of shares of unrestricted preferred stock payable in lieu
of a bonus  otherwise  payable shall be determined by dividing such bonus amount
by the fair market value of one share of  preferred  stock on the date the bonus
is payable, with fair market value determined as of such date in accordance with
Section 5(d)(ii).

     (B) In lieu of  salaries  and fees  otherwise  payable  by the  Company  to
employees,  attorneys and consultants  eligible to participate in this Plan that
were incurred for services rendered, the Committee, in its sole discretion,  may
determine  that such unpaid  salaries and fees shall be payable in  unrestricted
preferred  stock or partly in  unrestricted  preferred stock and partly in cash.
Such awards shall be in consideration of services previously performed and as an
incentive  toward future  services and shall  consist of shares of  unrestricted
common stock  subject to such terms as the  Committee  may determine in its sole
discretion. The number of shares of unrestricted preferred stock payable in lieu
of a salaries and fees  otherwise  payable  shall be determined by dividing each
calendar  month's  of unpaid  salary or fee amount by a  conversion  price to be
determined by the Committee in its sole discretion.

     (xi) No Rights as  Stockholder.  No Participant  shall have any rights as a
stockholder  with  respect to shares  covered  by a  preferred  stock  until the
preferred stock is converted as provided in clause (b)(iii) above.

                                       12
<PAGE>
     (xii) Extraordinary  Corporate  Transactions.  The existence of outstanding
preferred stock shall not affect in any way the right or power of the Company or
its stockholders to make or authorize any or all adjustments, recapitalizations,
reorganizations,  exchanges, or other changes in the Company's capital structure
or its business,  or any merger or consolidation of the Company, or any issuance
of common stock or other  securities  or  subscription  rights  thereto,  or any
issuance of bonds,  debentures,  preferred or prior preference stock ahead of or
affecting  the  common  stock  or the  rights  thereof,  or the  dissolution  or
liquidation  of the  Company,  or any sale or transfer of all or any part of its
assets or  business,  or any other  corporate  act or  proceeding,  whether of a
similar  character  or  otherwise.  If the Company  recapitalizes  or  otherwise
changes its capital structure, or merges, consolidates,  sells all of its assets
or dissolves (each of the foregoing a "Fundamental  Change"),  then  thereafter,
upon any conversion of preferred  stock  theretofore  granted,  the  Participant
shall be entitled  to the number of shares of common  stock upon  conversion  of
such  preferred  stock,  in lieu of the  number of shares of common  stock as to
which preferred stock shall then be convertible,  the number and class of shares
of stock  and  securities  to which the  Participant  would  have been  entitled
pursuant to the terms of the Fundamental  Change if,  immediately  prior to such
Fundamental  Change, the Participant had been the holder of record of the number
of shares of common stock as to which such preferred stock is then  convertible.
If (i)  the  Company  shall  not be  the  surviving  entity  in  any  merger  or
consolidation  (or survives  only as a subsidiary of another  entity),  (ii) the
Company  sells all or  substantially  all of its  assets to any other  person or
entity  (other  than a  wholly-owned  subsidiary),  (iii)  any  person or entity
(including a "group" as  contemplated  by Section  13(d)(3) of the Exchange Act)
acquires or gains ownership or control of (including,  without limitation, power
to vote)  more than 50% of the  outstanding  shares of  common  stock,  (iv) the
Company  is  to be  dissolved  and  liquidated,  or  (v)  as a  result  of or in
connection  with a  contested  election  of  directors,  the  persons  who  were
directors  of the Company  before such  election  shall  cease to  constitute  a
majority  of the Board  (each  such event in clauses  (i)  through  (v) above is
referred  to  herein  as a  "Corporate  Change"),  the  Committee,  in its  sole
discretion, may accelerate the time at which all or a portion of a Participant's
shares of preferred  stock may be converted for a limited  period of time before
or after a specified date.

     (xiii) Changes in Company's Capital Structure. If the outstanding shares of
common  stock  or other  securities  of the  Company,  or both,  for  which  the
preferred  stock is then  convertible  at any time be  changed or  exchanged  by
declaration  of  a  stock   dividend,   stock  split,   combination  of  shares,
recapitalization,  or  reorganization,  the  number and kind of shares of common
stock or other  securities  which  are  subject  to the Plan or  subject  to any
preferred stock theretofore granted, and the conversion ratio, shall be adjusted
only as provided in the designation of the preferred stock.

     (xiv) Acceleration of Conversion of Preferred Stock. Except as hereinbefore
expressly  provided,  (i) the  issuance by the Company of shares of stock or any
class of  securities  convertible  into shares of stock of any class,  for cash,
property,  labor or services, upon direct sale, upon the conversion of rights or
warrants to subscribe  therefor,  or upon conversion of shares or obligations of
the Company  convertible into such shares or other securities,  (ii) the payment
of a dividend in property other than common stock or (iii) the occurrence of any
similar  transaction,  and in any case whether or not for fair value,  shall not
affect,  and no adjustment by reason  thereof shall be made with respect to, the
number of shares of common stock subject to preferred stock theretofore granted,
unless the Committee shall determine, in its sole discretion, that an adjustment
is necessary to provide  equitable  treatment  to  Participant.  Notwithstanding
anything to the contrary  contained in this Plan, the Committee may, in its sole
discretion,  accelerate the time at which any preferred  stock may be converted,

                                       13
<PAGE>
including,  but not limited to, upon the  occurrence of the events  specified in
this Section 7(xiv).

SECTION 8. AMENDMENTS OR TERMINATION.

The Board may amend,  increase,  alter or discontinue the Plan, but no amendment
or  alteration  shall be made which would impair the rights of any  Participant,
without his consent,  under any option,  warrant or preferred stock  theretofore
granted.

SECTION 9. COMPLIANCE WITH OTHER LAWS AND REGULATIONS.

The Plan, the grant and exercise of options or warrants and grant and conversion
of preferred  stock  thereunder,  and the  obligation of the Company to sell and
deliver shares under such options, warrants or preferred stock, shall be subject
to all  applicable  federal and state laws,  rules and  regulations  and to such
approvals by any  governmental  or  regulatory  agency as may be  required.  The
Company shall not be required to issue or deliver any certificates for shares of
common stock prior to the completion of any  registration  or  qualification  of
such  shares  under  any  federal  or state  law or  issuance  of any  ruling or
regulation  of any  government  body  which  the  Company  shall,  in  its  sole
discretion, determine to be necessary or advisable. Any adjustments provided for
in subparagraphs 5(d)(xii), (xiii) and (xiv) shall be subject to any shareholder
action  required  by the  corporate  law of the  state of  incorporation  of the
Company.

SECTION 10. PURCHASE FOR INVESTMENT.

Unless the options,  warrants,  shares of convertible preferred stock and shares
of common stock covered by this Plan have been  registered  under the Securities
Act of 1933, as amended, or the Company has determined that such registration is
unnecessary, each person acquiring or exercising an option or warrant under this
Plan or converting  shares of preferred  stock may be required by the Company to
give a  representation  in writing  that he or she is  acquiring  such option or
warrant or such shares for his own account  for  investment  and not with a view
to, or for sale in connection with, the distribution of any part thereof.

SECTION 11. TAXES.

     (a) The Company may make such provisions as it may deem appropriate for the
withholding of any taxes which it determines is required in connection  with any
options, warrants or preferred stock granted under this Plan.

     (b)  Notwithstanding the terms of Paragraph 11 (a), any Participant may pay
all or any  portion of the taxes  required to be withheld by the Company or paid
by him or her in  connection  with the  exercise  of a  nonqualified  option  or
warrant  or  conversion  of  preferred  stock by  electing  to have the  Company
withhold  shares of common stock,  or by delivering  previously  owned shares of
common  stock,  having  a fair  market  value,  determined  in  accordance  with
paragraph  5(d)(ii),  equal to the amount  required to be  withheld  or paid.  A
Participant  must make the  foregoing  election  on or before  the date that the
amount of tax to be withheld is determined ("Tax Date").  All such elections are
irrevocable  and subject to disapproval  by the Committee.  Elections by Covered
Participants  are subject to the  following  additional  restrictions:  (i) such
election may not be made within six months of the grant of an option or warrant,
provided  that  this  limitation  shall  not  apply  in the  event  of  death or

                                       14
<PAGE>
disability,  and (ii) such election must be made either six months or more prior
to the Tax Date or in a Window  Period.  Where  the Tax  Date in  respect  of an
option or warrant is deferred  until six months  after  exercise and the Covered
Participant elects share withholding,  the full amount of shares of common stock
will be issued or transferred to him upon exercise of the option or warrant, but
he or she shall be  unconditionally  obligated to tender back to the Company the
number of shares necessary to discharge the Company's withholding  obligation or
his estimated tax obligation on the Tax Date.

SECTION 12. REPLACEMENT OF OPTIONS, WARRANTS AND PREFERRED STOCK.

The  Committee  from  time to time may  permit a  Participant  under the Plan to
surrender for  cancellation  any  unexercised  outstanding  option or warrant or
unconverted  Preferred stock and receive from the Company in exchange an option,
warrant or  preferred  stock for such number of shares of common stock as may be
designated by the  Committee.  The Committee may, with the consent of the holder
of any  outstanding  option,  warrant or  preferred  stock,  amend such  option,
warrant or preferred stock,  including reducing the exercise price of any option
or warrant  to not less than the fair  market  value of the common  stock at the
time of the amendment,  increasing the conversion  ratio of any preferred  stock
and  extending  the  exercise  or  conversion  term of and  warrant,  option  or
preferred stock.

SECTION 13. NO RIGHT TO COMPANY EMPLOYMENT.

Nothing in this Plan or as a result of any option or warrant granted pursuant to
this Plan shall confer on any  individual any right to continue in the employ of
the Company or  interfere  in any way with the right of the Company to terminate
an individual's  employment at any time. The option,  warrant or preferred stock
agreements  may contain  such  provisions  as the  Committee  may  approve  with
reference to the effect of approved leaves of absence.

SECTION 14. LIABILITY OF COMPANY.

The Company and any  Affiliate  which is in existence  or  hereafter  comes into
existence shall not be liable to a Participant or other persons as to:

     (a) The  Non-Issuance of Shares.  The  non-issuance or sale of shares as to
which the  Company has been  unable to obtain  from any  regulatory  body having
jurisdiction  the authority  deemed by the Company's  counsel to be necessary to
the lawful issuance and sale of any shares hereunder; and

     (b) Tax Consequences.  Any tax consequence  expected,  but not realized, by
any  Participant or other person due to the exercise of any option or warrant or
the conversion of any preferred stock granted hereunder.

                                       15
<PAGE>
SECTION 15. EFFECTIVENESS AND EXPIRATION OF PLAN.

The Plan shall be  effective  on the date the Board  adopts  the Plan.  The Plan
shall expire ten years after the date the Board approves the Plan and thereafter
no option, warrant or preferred stock shall be granted pursuant to the Plan.

SECTION 16. NON-EXCLUSIVITY OF THE PLAN.

Neither  the  adoption  by the  Board  nor  the  submission  of the  Plan to the
stockholders  of the Company for  approval  shall be  construed  as creating any
limitations on the power of the Board to adopt such other incentive arrangements
as it  may  deem  desirable,  including  without  limitation,  the  granting  of
restricted  stock or stock options,  warrants or preferred  stock otherwise than
under the Plan,  and such  arrangements  may be either  generally  applicable or
applicable only in specific cases.

SECTION 17. GOVERNING LAW.

This Plan and any agreements  hereunder  shall be  interpreted  and construed in
accordance  with  the laws of the  state of  incorporation  of the  Company  and
applicable federal law.

SECTION 18. CASHLESS EXERCISE.

The Committee also may allow cashless exercises subject to applicable securities
law  restrictions  or by any other  means that the  Committee  determines  to be
consistent with the Plan's purpose and applicable law.

Approved by the Board of Directors on May 29, 2012.

                                       16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}]]